Bai-Xue Yu

机构：State Key Laboratory of Respiratory Disease, Guangzhou Medical University

发表论文 5 篇 · 总被引 67 次 · h-index 4

代表论文

• Chimeric Peptide Engineered Bioregulator for Metastatic Tumor Immunotherapy through Macrophage Polarization and Phagocytosis Restoration (2023 · ACS Nano · 被引 28)
• Chimeric Peptide-Engineered Polyprodrug Enhances Cytotoxic T Cell Response by Inducing Immunogenic Cell Death and Upregulating Major Histocompatibility Complex Class I (2024 · ACS Nano · 被引 14)
• Plasma Membrane-Targeted Photooxidant for Chemotherapy-Enhanced Lipid Peroxidation (2022 · ACS Applied Bio Materials · 被引 11)
• Chimeric Peptide Functionalized Immunostimulant to Orchestrate Photodynamic Immunotherapeutic Effect by PD-L1 Deglycosylation and CD47 Inhibition (2025 · ACS Applied Materials & Interfaces · 被引 7)
• Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 Upregulation (2025 · ACS Applied Materials & Interfaces · 被引 2)